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The major joint registries report better survivorship for ceramic on polyethylene over metal 
on polyethylene bearings in total hip arthoplasty and it is generally accepted that this is due 
to a lower polyethylene wear rate. We used evidence synthesis to compare survivorship, 
polyethylene wear rates and metal ion levels for metal-on-polyethylene (MoP) and ceramic-
on-polyethylene (CoP) bearings. If wear rates are not dissimilar in vivo this difference in 
revision rate may have another cause. Modular junctions are a potential source of corrosion 
and it is postulated that this may result in higher revision rates.  
 Methods 
We performed a systematic review and meta-analysis comparing the survivorship of MoP and 
CoP bearings. Odds ratio (95% CI) of revision was calculated. Mean difference (MD) and 95% 
confidence intervals (CI) were used to compare secondary outcomes of polyethylene wear 
and metal ion levels. Meta-analysis was performed with a Mantel-Haenszel Random-Effects 
Model. 
Results 
Six randomised controlled trials were included. There was no statistically significant 
difference between MoP and CoP revision rate (OR: 1.04, 95% CI: 0.37 to 2.90, I2 = 0%, 
p=0.94), linear bearing wear (MD: 0.00mm, 95% CI: -0.05 to 0.05,I2=98%, p=0.90), nor 
volumetric bearing wear (MD: 33.57 mm3, 95% CI: -215.56 to 282.70,I2=98%, p=0.79). No 
studies evaluated metal ion levels.  
Conclusions 
We found no evidence of a difference in revision rates nor linear and volumetric wear 
between MoP and CoP bearings in the randomised controlled trials currently available. Our 
 
 
study therefore does not advocate the additional cost associated with the use of ceramic 
heads in combination with polyethylene bearings in order to minimise revision rates. This 
contrasts the findings of in-vitro studies and the major joint registries. 






The National Joint Registry of England, Wales, Northern Ireland and the Isle of Man (NJR) 
demonstrates a higher revision rate for MoP versus CoP bearings in the most commonly 
implanted prostheses in the UK as seen in table 1. The NJR also shows an increasing use of 
ceramic on polyethylene (CoP) compared to metal on polyethylene (MoP) [1]. If there is an 
in vivo decreased wear rate in CoP over MoP then this would help to justify the higher cost 
associated with this trend in bearing choice, particularly in the younger population where 
decreased polyethylene wear and resultant osteolysis is arguably more important in helping 
to reduce the risk of long-term revision. 
 
Several studies have demonstrated decreased in vitro wear with the use of CoP over MoP 
bearings [2-5]. This is thought to be due to ceramic heads having better wettability, 
decreased surface roughness and increased hardness and consequent increased resistance 
to scratching [6,7]. However doubt remains over the transferability of these results in-vivo, 
with the choice of lubricant and its serum protein concentration used for in-vitro studies 
having a dramatic impact on the amount of wear observed [8,9]. 
 
There is no high quality evidence comparing the wear rates of the two bearing combinations 
in vivo, with no large randomised controlled trials having been conducted. We therefore 
sought to discover whether the difference in revision rate between the two bearing 
combinations was due to differences in wear rate or some other phenomenon such as 
corrosion at the head neck taper [10], which may be reduced by the use of ceramic heads 
[11].  
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We performed a systematic review and meta-analysis of the outcomes of primary modular 
THA performed with MoP or CoP bearing couples to establish if there was:  
(i) a difference in overall revision rates between the bearing options;  
(ii) a difference in surrogate measures of trunnion corrosion such as serum metal ion 
levels;  
(iii) a difference in linear and volumetric bearing wear rates. 
 
   
 
 
Materials and Methods 
Data sources and search strategy  
Our review was conducted in accordance with the PRISMA and MOOSE guidelines (see 
appendix 2. Two independent reviewers (N.H. and T.G.F) screened MEDLINE, EMBASE, 
CINALH, the Cochrane Database for Systematic Reviews, and the Compendex of Engineering 
from inception to February 2017 for comparative or randomized studies in this topic. A 
language restriction to English was applied; however, both published and unpublished studies 
were sought. The search was comprised of several key words and Medical Subject Headings, 
these included: total hip arthroplasty, ceramic-on-polyethylene, metal-on-polyethylene, 
metal-on-metal, ceramic-on-ceramic, head-neck interface, adverse reaction to metal debris, 
corrosion, and implant failure. The search strategy was initially piloted with MEDLINE prior to 
being applied to the other databases. In addition to MoP and CoP bearings, we also included 
other bearing systems in the search to ensure comprehensiveness and that no relevant article 
was missed. Additionally, the bibliographies of all included articles were also examined by the 
independent reviewers. Finally, potential articles were also identified using the related article 
feature on PubMed. The full search criteria used can be seen in Appendix A. 
 
Eligibility criteria  
We included studies comprising of randomly allocated adult (>18 years of age) patients 
undergoing THA to either a MoP or CoP bearing combination. We excluded studies: (i) where 
patients were not randomly allocated to treatment group, (ii) studies that did not include 
both interventions of interest (MoP and CoP bearing combination). If it was not clear whether 
patients were randomly allocated to intervention group, attempts were made to contact the 




Data extraction and quality assessment  
Three independent reviewers (O.G., N.H. and T.G.F.) assessed each potential article for 
eligibility based on the defined inclusion/exclusion criteria and any discrepancies regarding 
eligibility of an article was discussed, and consensus reached with a fourth author (A.A.). Data 
extraction was independently carried out by two reviewers (N.H. and T.G.F.) to prevent error 
and ensure accuracy. The extraction form contained several items that were specific to both 
study methodology, and the primary and secondary outcomes assessed. In cases of 
discrepancy, both reviewers discussed until a consensus was reached. For multiple 
publications involving the same study, the most comprehensive study was used. We 
attempted to contact study investigators to provide any missing information. The 
methodological quality of the included randomized trials was assessed using the Cochrane 
Tool for assessment of risk of bias. Two independent reviewers (N.H. and T.G.F.) 
independently assessed the studies using questions which related to randomization, blinding, 
level of incomplete data reporting and selective outcome reporting. Due to the fact that 
surgical procedures were being performed and the outcomes of interest, blinding of the 
participants was not deemed to be relevant and this question was excluded from the 
assessment. An unweighted kappa (κ) was calculated to assess the agreement between the 
two independent reviewers. 
 
Statistical analysis 
Odds ratio (OR) with a 95% confidence interval (CI) was calculated for the total number of 
revisions. If follow-up times were reported, the data was further stratified; otherwise, the 
data was pooled irrespective of follow-up time. The secondary outcomes analysed were metal 
 
 
ion levels and bearing wear (to determine if differences in wear between the bearing couples 
could account for any differences in observed revision rates). The studies included in this 
review used varying methods for the quantification of wear. A mean difference (MD) with a 
95% CI was calculated when the same overall parameter was being measured. In situations 
where the measurement of a variable differed between studies, a standardized mean 
difference (SMD) with a 95% CI was calculated as a way to control for variation. Range values 
were converted into standard deviation (SD) using the equation SD=[max-min]/4 in 
accordance with Hozo et al. [12].  
Heterogeneity was evaluated through analysis of the I2 statistic. The threshold for conducting 
subgroup analyses was an I2>40%. As suggested by the Cochrane Handbook for Systematic 
Reviews, an I2 greater than this value suggests that heterogeneity may be present[13]. If 
heterogeneity was present, it was explored on the basis of overall study quality and femoral 
head size. 
In situations where data could be pooled, a meta-analysis was performed using the Mantel-
Haenszel Random-Effects Model since there was expected heterogeneity between the 
included studies. In cases when data could not be pooled, a summary and a graphical 






Study identification and selection  
Screening identified a total of 1996 potentially eligible articles. After elimination of duplicates, 
a total of 1629 articles were assessed. The majority were excluded as they were non-
randomized in nature, biomechanical studies, in vitro studies, or did not include the 
comparison of interest (figure 1). The full text of 11 articles were assessed, four were excluded 
as allocation was not randomised and one was excluded as detailed inspection revealed it did 
not contain the comparison group of interest. As such, a total of six randomized studies were 
included in this systematic review and meta-analysis. The raw agreement between reviewers 
was found to be 0.87 and the un-weighted κ was 0.74, which represents excellent agreement. 
 
Study characteristics and study quality  
A detailed overview of each of the included studies can be found in Table 2. Overall, there 
were a combined total of 693 patients (854 hips). The mean age of the patients ranged from 
61 to 69 years old. Follow up was relatively short for all studies, with a range from 2-8 years. 
Six of the studies were randomized controlled trials. Three studies exclusively utilized a 28mm 
head [14-16], one study exclusively used a 26mm head [17] and one study exclusively used a 
22mm head [18]. One study [19] randomized patients undergoing bilateral simultaneous THA 
to MoP 28mm, CoP 28mm, MoP 22mm, or CoP 22mm heads on each side. The hips for each 
patient were treated as independent events for the consideration of results from this study. 
The primary outcome of revision rate was reported by five studies [14-17,19]. Linear wear 
and volumetric wear [15,17,19], although Ise et al. measured volumetric wear rate per year. 
The secondary outcome of corrosion as assessed by the measurement of metal ion levels was 
not assessed by any of the studies. 
 
 
For the assessment of the risk of bias, the raw agreement between the reviewers was 83% 
and the un-weighted κ was calculated to be 0.81, which represents excellent agreement. One 
study reported randomizing patients on the basis of rolling a dice which, which was suggestive 
of a high risk of bias [17]. All six studies had good follow-up rates and had little incomplete 
data (Figure 2). 
 
Revision rates 
A total of five studies reported revision for MoP in comparison to CoP (542 patients) [14-
17,19]. A full list of the reported revisions can be seen in Table 3. Overall, the odds ratio of 
having a revision for any cause was not found to significantly different between patients that 
received MoP and those that received CoP (OR: 1.04, 95% CI: 0.37 to 2.90, I2 = 0%, p=0.94) 
(Figure 3).  
 
Metal ion levels 
None of the included studies evaluated metal ion levels. 
 
Linear wear 
Linear wear rate per year was assessed by five studies (406 hips) [15-19]. Two studies used 
28mm heads only [15,16], one study used 26mm heads [17], one study used 22mm heads 
[18] and one study used both 28 and 22mm heads [19]. The linear wear rate per year was not 
significantly different between the two bearing surfaces (MD: 0.00mm, 95% CI: -0.05-
0.05,I2=98%, p=0.90) (Figure 4). Subgroup analysis was performed on the basis of femoral 
head size, which included 22mm, 26mm, and 28mm. No significant differences were found 
between the subgroups with regard to linear wear rate per year as the size of the femoral 
 
 
head increased (X2 = 0.97, I2=0%, p=0.61) (Figure 5). However, a non-significant trend towards 
greater linear wear rates per year with progressively larger femoral head sizes was noted. 
 
Volumetric wear 
Four studies evaluated volumetric wear; however, one study evaluated volumetric wear rates 
per year and was not included in the statistical analysis [18]. This study, using 22mm heads, 
found no significant difference between CoP and MoP in regards to volumetric wear rate per 
year (p<0.05) [18]. Therefore, three studies (182 patients/306 hips) were used in the 
statistical analysis of volumetric wear [15,17,19]. One study used 28mm heads [15], one study 
used a 26mm head [17] and one study used 28 and 22mm heads [19]. Volumetric wear was 
not significantly different between the MoP and CoP groups (MD: 33.57mm3, 95% CI: -215.56-
282.70,I2=98%, p=0.79) (Figure 6). Subgroup analysis was performed on the basis of femoral 
head size, which included 22mm, 26mm, and 28mm. A 22 mm head size used with a CoP 
bearing was associated with significantly greater volumetric wear as compared with MoP 
(MD:-208.81, 95% CI: -351.52—66.10, I2 = N/A, P=0.004) (Figure 7). No significant difference 





Synthesis of the available randomised controlled trials comparing the revision rates of MoP 
and CoP THA has been performed. The available evidence shows no significant difference in 
revision rates, linear or volumetric bearing wear. None of the available studies reported the 
measurement of metal ion levels. 
The National Joint Registry of England, Wales, Northern Ireland and the Isle of Man (NJR) 
demonstrates a higher revision rate in MoP versus CoP bearings in the most commonly 
implanted prostheses in the geographical area covered (as seen in table 1 [20]). This 
difference is observed despite the average age of the CoP cohort being 10 years lower and 
therefore potentially at higher risk of revision due to higher activity levels and lower mortality 
rates over the period of observation.  
Commonly postulated possible reasons for a lower rate of revision in CoP bearing compared 
to MoP are a lower rate of bearing wear [21] and a reduced risk of trunnion corrosion [11]. 
The evidence in this paper contradicts the hypotheses that CoP bearings offer both lower risk 
of revision or reduced bearing wear than MoP bearings when assessed in randomised 
controlled trials at a follow up of up to 8 years.  
Irrespective of head size, our pooled data shows no statistically significant difference in linear 
wear between the two bearing combinations, nor a statistically significant difference in 
volumetric wear for all but the 22mm heads which showed an increase in wear for CoP over 
MoP. 
Data from NJR annual reports suggest that there may be a lower revision rate with CoP 
compared to MoP bearings [20] but other national joint registries’ annual reports do not 
support this [22-24]. The impact of head size on revision rate is also reported by the major 
joint registries; a low rate of revision for 32mm heads is reported in the NJR when compared 
 
 
to other head sizes [1] and a lower rate of revision for 32mm heads compared to those less 
than 32mm used in all of our included studies was reported by the Australian, New Zealand 
and Norwegian joint registries [22-24], Data available in national registry reports may be 
subject to confounding as surgeons and patients have selected one bearing type over the 
other options available and the bearing has not been randomly allocated as in the studies 
included in this paper. Registry data can demonstrate association between an intervention 
and an outcome of interest, whilst the issue of confounding can be tackled through controlling 
for patient, surgical and healthcare factors in the analysis of such data, there may still be 
residual confounding for example due to data not collected in the registry. Contemporary 
analysis of NJR data suggests no difference in the rates of revision for a diagnosis of adverse 
reaction to metal debris for MoP and CoP THA [25]. This finding is replicated in our study with 
no significant evidence that CoP bearings offer a better outcome than MoP at short to 
medium term follow up.  
This study has utilised robust, repeatable methods of evidence synthesis to determine if 
there is any difference in the rate of revision, linear or volumetric bearing wear between 
MoP and CoP THA. Our study has several limitations, whilst data was available on revision 
rate and bearing wear, none was available on metal ion levels which we had hoped to use as 
a surrogate marker of trunnion corrosion. None of the included studies used 
radiostereometric analysis, recognised as the best tool for detecting the small amounts of 
polyethylene wear in the early postoperative period [16,26]. The number of patients in the 
available studies was small and may therefore be underpowered. The available follow up in 
the published randomised controlled trials is relatively short and may not allow for all 
revisions due to wear or trunnion corrosion to be captured and reported. Both MoP and CoP 
bearings exhibit a bedding in and steady phase of wear and so early wear volumes may not 
 
 
be representative of the wear that can be expected over the lifetime of the implant. The 
included studies used different types of polyethylene, including non highly cross linked 
polyethylene [18], different types of ceramic including Zirconia (which, as far as we are 
aware, is not included in the NJR dataset for example), different types of metal head, 
different bearing sizes and different implants which may affect the pooling of data 
performed and may not be generalisable to all patients undergoing THA.  
 
Conclusion 
The data from this meta-analysis shows that polyethylene wear rates and survivorship of 
implants are comparable for MoP and CoP. At this stage data derived from RCTs does not 
support the additional costs associated with the use of ceramic heads over metal heads in 
combination with a polyethylene acetabulum. However the follow up in the included studies 
is short and the types of polyethylene and the zirconia ceramic used in the studies may mean 
that our meta-analysis is not generalisable to today’s practice. High quality evidence in 
regards to differences in metal ion levels between CoP and MoP is lacking and highlights an 
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Figure 1: PRISMA flow diagram of study inclusion 
Figure 2: Risk of bias of included studies (Green-low risk, Yellow-unclear risk, Red-high risk) 
Figure 3: Odds Ratios of Revision 
Figure 4: Linear wear rate per year (mm) 
Figure 5: Subgroup analysis by femoral head size of linear wear rate per year (mm) 
Figure 6: Volumetric wear rate (mm3) 






Table 1 NJR Revision Data 













































































Table 2: Study Characteristics  1 
 2 
Reference Methods Participants/Hips Intervention (total) 
[mean age] 









RCT; Norway 374 patients/397 
hips 




1. MoM metasul 28mm (n=123 
patients/129 hips)[63.3] 
2. CoP alumina on 
polyethylene28mm (n=124 
patients/131 hips)[63.9] 




7 - No significant difference in Harris Hip Score between MoP and CoP 
(p>0.05) 
- No significant difference in revisions between MoP and CoP (p>0.05) 
Ise, 2009 RCT; Japan 
Linear wear 
measurement: 
migration of centre of 
femoral head in 
relation to centre of 
cup using digitised 
radiographs validated 













MoP stainless steel 




1. CoP zirconia (Kyocera) on 
non cross linked 22mm 
(n=26 patients/23 hips) 
[60.0] 
2. CoP zirconia (Kyocera) on 
cross linked 22mm (n=17 
patients/25 hips)[61.6] 
3. CoP zirconia (Kobelco) on 














- Linear wear rate significantly lower in the CLPE Aeonian sockets of group B (CLPE sockets against 
Kyocera zirconia heads, 0.067 ± 0.044 mm/y), group C (CLPE sockets against Kobelco zirconia heads, 
0.059 ± 
0.027 mm/y), and group D (CLPE sockets against stainless 
steel heads, 0.068 ± 0.039 mm/y) compared with group A 
(non-CLPE sockets against Kyocera zirconia heads, 











chromium on highly 
crossed linked 
polyethylene 26mm 
1. CoP zirconia on highly cross 
linked polyethylene 26mm 









- No significant difference in both groups in regards to Linear Wear and 
Volumetric Wear (p>0.05) 
- No significant difference in revisions between MoP and CoP (p>0.05) 
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volumetric wear was 
calculated from the 
linear wear and 
the wear direction 
(n=29 patients/30 
hips)[61.1] 








V =  (V = 
volumetric wear,  = 
radius femoral head, 










1. MoP cobalt chrome on 
hylamer UHMWPE 22mm 
(35 patients/35 hips)[NR] 
2. CoP zirconia on hylamer 
UHMWPE 28mm (35 
patients/35 hips)[NR] 
3. CoP zirconia on hylamer 
UHMWPE 22mm (35 
hips)[NR] 





6.4 (5-7) - No significant difference in linear wear or volumetric wear between all 
groups (p>0.05) 
- Osteolysis was observed in six patients in both the MoP 28mm group 
and CoP 28mm group 











MoP cobalt chrome 
on UHMWPE 28mm 
(n=52 patients/52 
hips)[NR] 
1. CoP zirconia on UHMWPE 








7.1 (5-8) - Linear wear rate was significantly higher in the MoP group in 
comparison to CoP group (p<0.05) 
- Volumetric wear rate was significantly higher in the MoP group in 
comparison to the CoP group (p<0.05) 














1. CoP Zirconia on UHMWPE 









- No significant difference in head penetration rate between MoP and 
CoP (p>0.05) 
- No significant difference in revisions between MoP and CoP (p>0.05) 
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Determination of polyethylene wear in total hip 
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Table 3: Reported Revisions 1 
 MoP CoP 
 # Patients Hip Type # Revisions (cause) # Patients Hip Type # Revision (cause) 
Kim 
2005 
52 28 mm  0 52 28 mm  2 (aseptic looseing) 
Kawate 
2009 
29 26 mm  0 31 26 mm  0 
Bjorgul 
2013 
127 28 mm  3  
(2-dislocation; 
1-infection) 
124 28 mm  1 (infection)  
Kraay 
2006 
30 28 mm 0 27 28 mm 0 
Kim 
2001 
35 28 mm 6 (osteolysis) 35 28 mm 6 (osteolysis) 
 2 
Appendices 3 
Appendix 1: Search strategies 4 
MEDLINE Search Strategy 5 
1     exp Arthroplasty, Replacement, Hip/ (16882) 6 
2     (arthoplast$ adj2 (hip or femur or femoral)).mp. (47) 7 
3     exp hip joint/ (21240) 8 
4     (hip adj2 joint).mp. (26719) 9 
5     head neck interface.mp. (7) 10 
6     ((head adj2 neck) and hip).mp. (1022) 11 
7     exp Hip Prosthesis/ (18641) 12 
8     (hip adj2 replace$).mp. (22678) 13 
9     ((modular or taper) adj2 interface).mp. (52) 14 
10     trun?ion.mp. (65) 15 
11     or/1-10 (51745) 16 
12     exp prosthesis failure/ (21432) 17 
13     (prosthes?s adj2 fail$).mp. (21705) 18 
14     Implant Capsular Contracture.mp. (113) 19 
15     ae.fs. [adverse effect as a subheading] (1351511) 20 
 
 
16     adverse reaction to metal debris.mp. (29) 1 
17     armd.ti. (50) 2 
18     exp Corrosion/ (3866) 3 
19     (corrosion adj2 fret$).mp. (92) 4 
20     metalosis.mp. (8) 5 
21     exp Equipment Failure Analysis/ (30495) 6 
22     failure analys?s.mp. (31021) 7 
23     11 and (or/12-22) (16000) 8 
24     exp aluminum oxide/ (15814) 9 
25     aluminum oxide.mp. (6542) 10 
26     exp ceramics/ (16800) 11 
27     ceramic$.mp. (21311) 12 
28     porcelain.mp. (10536) 13 
29     ceramic on ceramic.mp. (330) 14 
30     or/24-29 [Ceramic including ceramic on ceramic] (40636) 15 
31     exp Chromium Alloys/ (3801) 16 
32     (cobalt adj2 chrome).ti,ab. (597) 17 
33     metal on metal.mp. (1441) 18 
34     exp metals/ (860651) 19 
35     metal.ti,ab. (167209) 20 
36     exp titanium/ (25137) 21 
37     titanium.mp. (37180) 22 
38     or/31-37 [all metal including metal on metal] (963291) 23 
39     exp Polyethylenes/ (13176) 24 
40     poly.ti,ab. (109237) 25 
41     Polyethylene.mp. (66587) 26 
42     or/39-41 (172120) 27 
43     23 and 30 and 38 [ceramic verus metal] (486) 28 
44     23 and 30 and 38 and 42 [ceramic, metal and poly] (315) 29 
45     23 and 30 and 42 [ceramic and poly] (395) 30 
46     23 and 38 and 42 [metal and poly] (1026) 31 
47     or/43-46 (1277) 32 
48     remove duplicates from 47 (1263) 33 
49     limit 48 to animals (54) 34 
50     48 not 49 (1209) 35 
51     limit 50 to english language (1064) 36 
 37 
EMBASE Search Strategy 38 
1     arthroplasty, Replacement, Hip.mp. (106) 39 
2     exp hip arthroplasty/ (13307) 40 
3     ((arthoplast$ or replace$) adj2 (hip or femur or femoral)).mp. (13707) 41 
4     hip joint/ (42414) 42 
5     head neck interface.mp. (7) 43 
 
 
6     ((head adj2 neck) and hip).mp. (1491) 1 
7     exp Hip Prosthesis/ (31493) 2 
8     ((modular or taper) adj2 interface).mp. (58) 3 
9     trun?ion.mp. (82) 4 
10     or/1-9 (82016) 5 
11     exp prosthesis failure/ (25873) 6 
12     (prosthes?s adj2 fail$).mp. (14740) 7 
13     Implant Capsular Contracture.mp. (183) 8 
14     ae.fs. [adverse events as a subheading] (1090809) 9 
15     adverse reaction to metal debris.mp. (32) 10 
16     armd.ti. (62) 11 
17     Corrosion/ (7380) 12 
18     (corrosion adj2 fret$).mp. (100) 13 
19     metalosis.mp. (15) 14 
20     exp Equipment Failure Analysis/ (3508) 15 
21     failure analys?s.mp. (1379) 16 
22     10 and (or/11-21) (12541) 17 
23     exp aluminum oxide/ (11317) 18 
24     aluminum oxide.mp. (11921) 19 
25     exp ceramics/ (13012) 20 
26     ceramic.mp. (17755) 21 
27     porcelain.mp. (5923) 22 
28     ceramic on ceramic.mp. (397) 23 
29     or/23-28 [Ceramic including ceramic on ceramic] (35396) 24 
30     22 and 29 (742) 25 
31     exp titanium/ (29737) 26 
32     exp chromium/ (33435) 27 
33     exp chromium derivative/ (4805) 28 
34     exp cobalt/ (37588) 29 
35     chrome.mp. (2990) 30 
36     titanium.mp. (49870) 31 
37     22 and (or/31-36) (1164) 32 
38     30 and 37 (217) 33 
39     exp polyethylene derivative/ or exp polyethylene/ (18037) 34 
40     Polyethylene.mp. (50144) 35 
41     poly.ti,ab. (120660) 36 
42     or/39-41 (167628) 37 
43     37 and 42 (454) 38 
44     30 and 42 (424) 39 
45     38 or 43 or 44 (791) 40 
46     remove duplicates from 45 (787) 41 
47     limit 46 to animal studies (13) 42 
48     46 not 47 (774) 43 
 
 
49     limit 48 to english language (709) 1 
 2 
COCHRANE Search Strategy 3 
1     hip arthroplasty.mp. (1462) 4 
2     ((head adj2 neck) and hip).mp. (39) 5 
3     (hip adj2 joint).mp. (1164) 6 
4     hip prosthesis.mp. (1343) 7 
5     trun?ion.mp. (1) 8 
6     1 or 2 or 3 or 4 or 5 (3124) 9 
7     ceramic.mp. (643) 10 
8     6 and 7 (69) 11 
9     (titanium or chrome or cobalt).mp. [mp=ti, ot, ab, tx, kw, ct, sh, hw] (1500) 12 
10     6 and 9 (119) 13 
11     polyethylene.mp. [mp=ti, ot, ab, tx, kw, ct, sh, hw] (2867) 14 
12     6 and 11 (186) 15 
13     8 and 10 (23) 16 
14     6 and 7 and 11 (51) 17 
15     9 and 11 (85) 18 
16     8 and 11 (51) 19 
17     13 or 14 or 15 or 16 (119) 20 
18     remove duplicates from 17 (117) 21 
19     limit 18 to english language [Limit not valid in CDSR,ACP Journal Club,DARE,CLCMR; 22 
 
 
Appendix 2: PRISMA and MOOSE Checklists 1 
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  3 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
4 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  6 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
8/9 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
- 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
8/9 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
8/9 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
27-30 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
8/9/11 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
8/9/11 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
8/9 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 




Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  9/10 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis.  
10 
 1 
Page 1 of 2  2 
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
12 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
12/13 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
figures 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
figures 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  figures 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
figures 
Synthesis of results  21 Present the main results of the review. If meta-analyses are done, include for each, confidence intervals and 
measures of consistency.  
11-13 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  21 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  12/13 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
14-16 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
15 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  15/16 
FUNDING   
 
 
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
n/a 
 1 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): 2 
e1000097. doi:10.1371/journal.pmed1000097  3 
 
 
MOOSE (Meta-analyses Of Observational Studies in Epidemiology) Checklist 1 
 2 
A reporting checklist for Authors, Editors, and Reviewers of Meta-analyses of Observational Studies. You must report the page 3 
number in your manuscript where you consider each of the items listed in this checklist. If you have not included this information, 4 
either revise your manuscript accordingly before submitting or note N/A. 5 
 6 
Reporting Criteria Reported (Yes/No) Reported on Page No. 
Reporting of Background   
Problem definition Yes 6 
Hypothesis statement Yes 7/8 
Description of Study Outcome(s) Yes 10/11 
Type of exposure or intervention used Yes 12 
Type of study design used Yes 12 
Study population Yes 25 
Reporting of Search Strategy   
Qualifications of searchers (eg, librarians 
and investigators) 
Yes 9 
Search strategy, including time period 
included in the synthesis and keywords 
Yes 9  
Effort to include all available studies, 
including contact with authors 
Yes 9/10 
Databases and registries searched Yes 9 
Search software used, name and 
version, including special features used 
(eg, explosion) 
Yes 9  
Use of hand searching (eg, reference 
lists of obtained articles) 
Yes 9 
List of citations located and those 
excluded, including justification 
Yes figures 
Method for addressing articles 
published in languages other than 
English 
Yes 9 
Method of handling abstracts and 
unpublished studies 
Yes 9 
Description of any contact with authors No n/a 
Reporting of Methods   
Description of relevance or 
appropriateness of studies assembled for 
assessing the hypothesis to be tested 
Yes 12-13 
Rationale for the selection and coding of 
data (eg, sound clinical principles or 
convenience) 
Yes 10 
Documentation of how data were 
classified and coded (eg, multiple raters, 
blinding, and interrater reliability) 
Yes 10 
Assessment of confounding (eg, 
comparability of cases and controls in 





Reporting Criteria Reported (Yes/No) Reported on Page No. 
Assessment of study quality, including 
blinding of quality assessors; 
stratification or regression on possible 
predictors of study results 
Yes 10 
Assessment of heterogeneity Yes 11 
Description of statistical methods (eg, 
complete description of fixed or random 
effects models, justification of whether 
the chosen models account for predictors 
of study results, dose-response models, 
or cumulative meta-analysis) in sufficient 
detail to be replicated 
  
Provision of appropriate tables and 
graphics 
Yes figures 
Reporting of Results   
Table giving descriptive information for 
each study included 
yes 25-26 
Results of sensitivity testing (eg, 
subgroup analysis) 
yes 13/14/figures 
Indication of statistical uncertainty of 
findings 
Yes 13/14 
Reporting of Discussion   
Quantitative assessment of bias (eg, 
publication bias) 
Yes 22 
Justification for exclusion (eg, exclusion 
of non–English-language citations) 
Yes 9/20 
Assessment of quality of included studies Yes 9/12/13 
Reporting of Conclusions   
Consideration of alternative explanations 
for observed results 
Yes 16 
Generalization of the conclusions (ie, 
appropriate for the data presented and 
within the domain of the literature review) 
Yes 16/17 
Guidelines for future research No n/a 
Disclosure of funding source No n/a 
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